Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RG1662 effect on metformin in healthy volunteers
NCT02342925Phase 1Completed
- Sponsor
- Roche
- Start
- Feb 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of basmisanil in cognitive impairment (2 arms), sponsored by Roche. Primary endpoint: Pharmacokinetic parameters of metformin at 9 weeks. Started Feb 2015; status: completed.
02
Drugs
basmisanil
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT02342925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342925.